First Light Asset Management, LLC
CIK: 0001600004Latest portfolio: $1.3B · Q4 2025
Holdings
33
Total Value
$1.3B
New Positions
6
Closed Positions
14
Top Holdings
View All 33 Holdings →| # | Stock | Shares | Value | % Portfolio | Change | Type |
|---|---|---|---|---|---|---|
| 1 | AXGNAXOGEN INC | 5,233,326 | $171.3M | 13.10% | -572,404 | |
| 2 | NEONEOGENOMICS INC | 10,035,063 | $118.0M | 9.02% | +108K | |
| 3 | SIBNSI-BONE INC | 5,032,904 | $99.2M | 7.59% | +3.1M | |
| 4 | PVLAPALVELLA THERAPEUTICS INC | 709,141 | $74.2M | 5.67% | +168K | |
| 5 | CNTACENTESSA PHARMACEUTICALS LIMITED | 2,278,940 | $57.0M | 4.36% | -1,356,876 | |
| 6 | CRNXCRINETICS PHARMACEUTICALS INC | 1,194,263 | $55.6M | 4.25% | +253K | |
| 7 | ATRCATRICURE INC | 1,175,445 | $46.5M | 3.56% | +285K | |
| 8 | VERAVERA THERAPEUTICS INC | 869,676 | $44.0M | 3.37% | +363K | |
| 9 | IRONDISC MEDICINE INC | 523,167 | $41.5M | 3.18% | +292K | |
| 10 | AMLXAMYLYX PHARMACEUTICALS INC | 3,355,539 | $40.5M | 3.10% | -343 | |
| 11 | EWTXEDGEWISE THERAPEUTICS INC | 1,573,701 | $39.1M | 2.99% | +159K | |
| 12 | MDGLMADRIGAL PHARMACEUTICALS INC | 66,831 | $38.9M | 2.98% | +55K | |
| 13 | TWSTTWIST BIOSCIENCE CORPORATION | 1,140,771 | $36.2M | 2.77% | -54,112 | |
| 14 | SLPSIMULATIONS PLUS INC | 1,968,917 | $35.9M | 2.74% | +1.2M | |
| 15 | RYTMRHYTHM PHARMACEUTICALS INC | 295,844 | $31.7M | 2.42% | +115K | |
| 16 | WVEWAVE LIFE SCIENCES LTD | 1,853,851 | $31.5M | 2.41% | NEW | |
| 17 | ANABANAPTYS BIO INC | 646,238 | $31.3M | 2.40% | -343,923 | |
| 18 | HCATHEALTH CATALYST INC | 12,910,941 | $30.9M | 2.36% | -525,279 | |
| 19 | GHGUARDANT HEALTH | 294,751 | $30.1M | 2.30% | +15K | |
| 20 | IRTCIRHYTHM TECHNOLOGIES | 153,871 | $27.3M | 2.09% | -1,228 | |
| 21 | ESTAESTABLISHMENT LABS HOLDINGS | 373,082 | $27.2M | 2.08% | -45,276 | |
| 22 | MASS908 DEVICES INC | 4,836,186 | $25.4M | 1.94% | +2.3M | |
| 23 | KRMDKORU MEDICAL SYSTEMS INC | 4,210,512 | $24.5M | 1.87% | -317,225 | |
| 24 | TNDMTANDEM DIABETES CARE INC | 1,089,493 | $23.9M | 1.83% | NEW | |
| 25 | APGEAPOGEE THERAPEUTICS INC | 284,991 | $21.5M | 1.64% | NEW |
Quarterly Changes
Increased Positions
Sector Breakdown
Healthcare0.0% ($1.712861180129925e+151T)
Financial Services0.0% ($245K)
Filing History
| Quarter | Filing Date | Portfolio Value | Holdings |
|---|---|---|---|
| Q4 2025 | Feb 17, 2026 | $1.3B | 33 |
| Q3 2025 | Nov 14, 2025 | $1.1T | 41 |
| Q2 2025 | Aug 14, 2025 | $771.3B | 38 |
| Q1 2025 | May 15, 2025 | $875.7B | 37 |
| Q4 2024 | Feb 14, 2025 | $1.0T | 36 |
| Q3 2024 | Nov 14, 2024 | $1201.9T | 38 |
| Q2 2024 | Aug 14, 2024 | $1140.8T | 44 |
| Q1 2024 | May 15, 2024 | $1306.1T | 50 |
| Q4 2023 | Feb 14, 2024 | $1243.0T | 75 |
| Q3 2023 | Nov 14, 2023 | $1052.8T | 75 |
| Q2 2023 | Aug 14, 2023 | $1275.9T | 79 |
| Q1 2023 | May 15, 2023 | $1110.6T | 74 |
| Q4 2022 | Feb 14, 2023 | $1077.4T | 74 |
| Q3 2022 | Nov 14, 2022 | $988.1B | 71 |
| Q2 2022 | Aug 12, 2022 | $859.4B | 71 |
| Q1 2022 | May 13, 2022 | $1.1T | 75 |
| Q4 2021 | Feb 14, 2022 | $1.4T | 79 |
| Q3 2021 | Nov 12, 2021 | $1.5T | 83 |
| Q2 2021 | Aug 13, 2021 | $1.7T | 79 |
| Q1 2021 | May 17, 2021 | $1.5T | 77 |
| Q4 2020 | Feb 16, 2021 | $1.4T | 74 |
| Q3 2020 | Nov 13, 2020 | $976.0B | 60 |
| Q2 2020 | Aug 14, 2020 | $858.2B | 60 |
| Q1 2020 | May 15, 2020 | $585.8B | 64 |
| Q4 2019 | Feb 14, 2020 | $782.3B | 69 |
| Q3 2019 | Nov 14, 2019 | $661.5B | 71 |
| Q2 2019 | Aug 14, 2019 | $720.2B | 73 |
| Q1 2019 | May 15, 2019 | $769.6B | 63 |
| Q4 2018 | Feb 14, 2019 | $627.2B | 59 |
| Q3 2018 | Nov 14, 2018 | $619.8B | 59 |
| Q2 2018 | Aug 14, 2018 | $642.3B | 55 |
| Q1 2018 | May 15, 2018 | $455.4B | 52 |
| Q4 2017 | Feb 14, 2018 | $364.7B | 52 |
| Q3 2017 | Nov 14, 2017 | $315.8B | 52 |
| Q2 2017 | Aug 14, 2017 | $298.1B | 55 |
| Q1 2017 | May 15, 2017 | $261.9B | 52 |
| Q4 2016 | Feb 14, 2017 | $227.5B | 54 |
| Q3 2016 | Nov 15, 2016 | $232.3B | 68 |
| Q2 2016 | Aug 15, 2016 | $215.9B | 65 |
| Q1 2016 | May 16, 2016 | $198.2B | 67 |
Fund Information
First Light Asset Management, LLC is an institutional investment manager that files 13F reports with the SEC. As of the Q4 2025 filing, the fund reported a portfolio valued at $1.3B across 33 holdings. The largest position is AXOGEN INC (AXGN), representing 13.1% of the portfolio. Compared to the previous quarter, the fund opened 6 new positions and closed 14 positions. 13F filings are required quarterly disclosures that provide transparency into the holdings of institutional investment managers with at least $100 million in qualifying assets.